News
Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding ...
Long-term clinical evaluation represents key advancement following successful first-in-human studyRUTHERFORD, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or ...
Continuous glucose monitoring provides a new, less invasive method for evaluating diabetes risk. Fluctuations in blood ...
Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...
Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...
Roche Holding (SWX:ROG) recently announced a significant investment of $550 million in its Indianapolis Diagnostics site to ...
How wearables are reshaping chronic disease management with real-time data, personalized treatment, and early intervention ...
Interesting Engineering on MSN6d
New wearable tech detects diabetes risk early, eliminates need for needle pricksContinuous glucose monitoring can now spot early diabetes risks, offering a non-invasive alternative to traditional blood ...
The Swiss biotech company Roche on Monday announced plans for a $550 million expansion of its Indianapolis diagnostics and ...
Dr Ray O’Connor continues his look at the latest clinical articles on the importance of lifestyle advice in doctor-patient ...
Verywell Health on MSN1d
How Meal Sequencing Could Prevent Blood Sugar SpikesSome people swear by meal sequencing—the practice of eating foods in a specific order. But some experts say it's not worth it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback